TransCelerate creates pragmatic solutions, such as templates, guidance, model frameworks and systems, that addresses barriers and issues that are negatively impacting the ability of the biopharmaceutical industry to bring medicines to patients that need them. These solutions are developed collaboratively and can be voluntarily adopted by stakeholders in the clinical research ecosystem.
Evolution of a TransCelerate Initiative
- Patients and Sites: Our patient focused initiatives are centered around improving how patients experience their journey before, during and after a clinical trial, and seeks to better inform patients, their caregivers and healthcare providers by facilitating improved touchpoints with clinical research information. Part of our strategic priorities is providing clinical trial staff resources to reduce redundancy and unnecessary work for sites in managing clinical trials. Our site initiatives ensure stakeholders understand and embrace the site’s essential role in clinical research.
- Information Sharing & Harmonization: While many of our active initiatives are focused on specific stakeholders involved in clinical trials, our Information Sharing & Harmonization Initiatives support the entire clinical study lifecycle by developing innovative solutions that enable and facilitate data sharing and harmonization through enhanced technology and aligned common processes, while protecting individuals’ privacy. This will help streamline communication and enhance information sharing across the industry.
- Sponsors & Drug Safety: Sponsors have a responsibility to run safe and efficient clinical investigations, therefore our sponsor initiatives are focused on facilitating strategic planning and important engagement with many clinical research stakeholders. Specifically, for human subject research, sponsors are consistently working toward maintaining quality best practices, reducing inherent risks, ensuring accurate data management, integrity and transparency throughout the clinical trial process from study planning to study closure and beyond. In addition, our drug safety work creates solutions to reduce resource inefficiencies, enhance information exchange with global health authorities and improve patient safety to drive more value for patients.
*Voluntary for member companies.
Want more? These videos talk about our Initiatives and the solutions we make available to the industry. Check them out!
Overview: Sites-Focused Initiatives
Overview: Sponsor-Focused Initiatives
Overview: Patient-Focused Initiatives
Overview: Initiatives Focused on Information Sharing & Harmonization
As we continue to collectively advance our ongoing initiatives, we are also looking to leverage the rich diversity of experiences and perspectives across our member companies to identify areas to further explore. Find out more about the Ideation Challenge.